SME Instrument Award

RemAb Therapeutics has been awarded a Small and Medium-sized Enterprises (SME) instrument phase-1 Grant for our project of preventing hospital-acquired infections. This Grant is a part of the Horizon 2020 Work programme 2018-2020.

Learn more